IM Cannabis (IMCC)
(Delayed Data from NSDQ)
$2.34 USD
+0.03 (1.30%)
Updated Sep 9, 2024 03:59 PM ET
After-Market: $2.34 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for IM Cannabis Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 36 | 42 | 43 | 12 | NA |
Cost Of Goods | 29 | 33 | 34 | 5 | NA |
Gross Profit | 7 | 9 | 9 | 7 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 17 | 32 | 40 | 13 | 0 |
Income After Depreciation & Amortization | -9 | -24 | -31 | -6 | 0 |
Non-Operating Income | 5 | 5 | 18 | 0 | NA |
Interest Expense | 3 | 2 | 1 | 15 | NA |
Pretax Income | -7 | -20 | -14 | -21 | NA |
Income Taxes | 1 | -1 | 0 | 0 | NA |
Minority Interest | -1 | -2 | -1 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -8 | -19 | -15 | -21 | NA |
Extras & Discontinued Operations | 0 | -128 | 0 | 0 | NA |
Net Income (GAAP) | -7 | -145 | -14 | -21 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -20 | -27 | -6 | 0 |
Depreciation & Amortization (Cash Flow) | 2 | 4 | 3 | 1 | NA |
Income After Depreciation & Amortization | -9 | -24 | -31 | -6 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2.14 | 1.17 | 0.96 | 0.64 | NA |
Diluted EPS Before Non-Recurring Items | -3.30 | -17.58 | -31.79 | -32.99 | NA |
Diluted Net EPS (GAAP) | -3.29 | -124.49 | -31.59 | -33.14 | NA |
Fiscal Year end for IM Cannabis Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 10.78 | 8.94 | 7.37 | 9.22 | 9.82 |
Cost Of Goods | 10.16 | 7.62 | 7.24 | 7.25 | 7.25 |
Gross Profit | 0.62 | 1.32 | 0.13 | 1.97 | 2.57 |
SG&A, R&D, and Dept/Amort Expenses | 2.71 | 5.49 | 4.42 | 3.65 | 3.87 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.09 | -4.17 | -4.29 | -1.68 | -1.30 |
Non-Operating Income | 0.00 | -0.01 | 2.20 | 0.18 | 0.00 |
Interest Expense | 1.04 | 0.36 | 0.56 | 0.00 | 1.57 |
Pretax Income | -3.14 | -4.54 | -2.65 | -1.50 | -2.88 |
Income Taxes | -0.61 | -0.08 | 0.61 | 0.09 | -0.12 |
Minority Interest | -0.31 | -0.29 | -0.17 | 0.01 | -0.18 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.53 | -4.46 | -3.26 | -1.59 | -2.76 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.21 | -4.17 | -3.09 | -1.60 | -2.57 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 13.17 | 2.23 | 2.35 | 2.23 | 2.20 |
Diluted EPS Before Non-Recurring Items | -0.17 | -0.96 | -1.08 | -0.72 | -1.14 |
Diluted Net EPS (GAAP) | -0.17 | -1.87 | -1.55 | -0.72 | -1.16 |